Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CASP1 | P29466 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.53 |
| ▸ | DHODH | Q02127 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Furan SCHEMBL27902429 | 0.75 | MAPK1 (0.47) | MAPK1TDP1CA1CA9 | |
| Maleic Anhydride SCHEMBL4453246 | 0.75 | MAPK1 (0.47) | MAPK1TDP1ALDH1A1HSD17B10CA1 | |
| Benzoquinone SCHEMBL5335267 | 0.73 | MAOA (0.80) | MAPK1TDP1ALDH1A1BCHEPOLB | |
| Furan SCHEMBL4603105 | 0.73 | GSK3A (0.61) | MAPK1TDP1CA1CA9 | |
| Furan SCHEMBL419906 | 0.73 | — | — | |
| Furan SCHEMBL315 | 0.73 | — | — | |
| Benzoquinone SCHEMBL460082 | 0.73 | ALDH1A1 (1.00) | MAPK1TDP1ALDH1A1BCHEPOLB | |
| Benzoquinone SCHEMBL10506648 | 0.73 | ALDH1A1 (1.00) | MAPK1TDP1ALDH1A1BCHEPOLB | |
| Benzoquinone SCHEMBL5308519 | 0.73 | ALDH1A1 (1.00) | MAPK1TDP1ALDH1A1BCHEPOLB | |
| Benzoquinone SCHEMBL18103 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115874201-A | Electric synthesis method of furan quinone | 南京工业大学 | 2023-03-31 | — | — | CN | claimed |
| WO-2023146457-A2 | A METHOD AND DEVICE FOR ELECTROCHEMICAL HYDROGENATION OF LIQUID ORGANIC HYDROGEN CARRIERS | GHORBANI SHIRAZ HAMID (SE) | 2023-08-03 | — | — | WO | disclosed |
| CN-115874201-A | Electric synthesis method of furan quinone | 南京工业大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-115874201-A | Electric synthesis method of furan quinone | 南京工业大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-115874201-A | Electric synthesis method of furan quinone | 南京工业大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-110381963-A | It is related to the immunotherapy method and composition of tryptophan metabolic pathway regulator | 朱诺治疗学股份有限公司 | 2019-10-25 | — | — | CN | disclosed |
| CN-103167904-B | Separate film, separating film element and separation film manufacturing method | 东丽株式会社 | 2016-10-26 | — | — | CN | disclosed |
| CN-103459003-B | Spiral separation membrane element and manufacture method thereof | TORAY INDUSTRIES, INC. (JP) | 2016-04-06 | — | — | CN | disclosed |
| CN-103338846-B | Separation membrane for water treatment and manufacture method thereof | TORAY INDUSTRIES, INC. (JP) | 2015-07-29 | — | — | CN | disclosed |
| US-20140154319-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | KWAK TAEHWAN (KR) | 2014-06-05 | — | — | US | disclosed |
| US-20100137422-A1 | NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME | YUNGJIN PHARM. CO., LTD. (KR) | 2010-06-03 | — | — | US | disclosed |
| EP-2137175-A1 | NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME | Mazence Inc. (KR) | 2009-12-30 | — | — | EP | disclosed |
| EP-2094262-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM | Mazence Inc. (KR) | 2009-09-02 | — | — | EP | disclosed |
| WO-2009084834-A2 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | MAZENCE INC. (KR) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009084835-A2 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF KIDNEY DISEASES | MAZENCE INC. (KR) | 2009-07-09 | — | — | WO | disclosed |
| WO-2008133441-A1 | NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME | MAZENCE INC. (KR) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008066301-A1 | ANTICANCER COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM | MAZENCE INC. (KR) | 2008-06-05 | — | — | WO | disclosed |
| WO-2008066296-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PHENANTHRENEQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM | MAZENCE INC. (KR) | 2008-06-05 | — | — | WO | disclosed |
| US-4225645-A | CONTAINING A HEXAALKOXYMETHYL MELAMINE | UNIROYAL, INC. (US) | 1980-09-30 | — | — | US | disclosed |
| US-4168163-A | TREATING WITH LIQUID CONTAINING COLLOIDAL ALUMINA | FUJI PHOTO FILM CO., LTD. (JP) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140154319-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF CARDIAC DISEASE | TNNT2, TNNC1, TNNI3 | MAPK1 2114/4885TDP1 866/4885ALDH1A1 842/4885 |
| US-20100137422-A1 | NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME | CYP27A1, CYP46A1, PCSK9 | MAPK1 1824/4885TDP1 1435/4885ALDH1A1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.